SEPTIN1

Across TCGA pan-cancer cohorts, SEPTIN1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SEPTIN1 data layer compared with 26 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher SEPTIN1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SEPTIN1 expression acts as an unfavorable survival marker, although some lineages such as PDAC and LUAD show a favorable association.

PDAC, LUAD, and HNSC are the cancer types where SEPTIN1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.852	0.666	<.001	67	view →
LUAD	DFS	Median	All	0.790	0.487	<.001	26	view →
HNSC	DFS	Median	II,III,IV	0.891	0.993	.003	12	view →
CCRCC	OS	Tertile	All	1.000	0.638	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SEPTIN1–PDAC (DFS)

Open the PDAC breakdown →